Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
Launched by UNIVERSITY OF VIRGINIA · Jul 6, 2006
Trial Information
Current as of October 30, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteers must have meet the definition of the metabolic syndrome (based on IDF consensus statement).
- • Screening biochemical tests of liver, kidney, hematologic, metabolic (below) and thyroid function must be normal.
- * The volunteer must be willing to:
- • 1. visit the outpatient GCRC or clinic once monthly for 16 weeks of intervention,
- • 2. participate in supervised exercise training (if assigned) and
- • 3. enter the inpatient GCRC for 2-3 days of more intensive studies at baseline and after 16 weeks of intervention. The subject must provide voluntary and fully informed written consent.
- Exclusion Criteria:
- • Type 1 diabetes,
- • drug or alcohol abuse,
- • psychosis,
- • severe or untreated depression,
- • dementia, polycythemia (hematocrit \> 55%),
- • clinically symptomatic coronary artery,
- • pulmonary or orthopedic disease (which would disallow exercise training),
- • history of vascular or peripheral nerve trauma,
- • lymph node dissection,
- • anemia, uncontrolled hypertension (\> 160/105 untreated or \> 145/95 treated),
- • allergic to octafluoropropane, or nitroglycerine,
- • weight loss or gain of 2 kg or more within the preceding 10 days,
- • investigational drug use within five biological half-lives,
- • treatment with ACE inhibitors or ARBs, thiazolindiones,
- • 1st or 2nd generation anti-psychotics insulin, or Viagra,
- • unwillingness to provide written informed voluntary consent,
- • pregnant, breast feeding or use hormonal birth control.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Patients applied
Trial Officials
Arthur Weltman, PhD
Principal Investigator
University of Virginia
Brian A Irving, PhD
Study Director
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials